Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer.

Squires H, Tappenden P, Cooper K, Carroll C, Logan R, Hind D.

Clin Ther. 2011 Sep;33(9):1289-305. doi: 10.1016/j.clinthera.2011.07.009. Epub 2011 Aug 12.

PMID:
21840057
2.

Use of Aspirin and NSAIDs to Prevent Colorectal Cancer [Internet].

Rostom A, Dube C, Lewin G.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Mar.

3.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

5.

Diabetes, colorectal cancer and cyclooxygenase 2 inhibition.

Smith CJ, McKay GA, Fisher M.

Int J Clin Pract. 2008 May;62(5):810-5. doi: 10.1111/j.1742-1241.2008.01726.x. Epub 2008 Mar 25. Review.

PMID:
18373616
6.
7.

Is no NSAID a good NSAID? Approaches to NSAID-associated upper gastrointestinal disease.

Chang SY, Howden CW.

Curr Gastroenterol Rep. 2004 Dec;6(6):447-53. Review.

PMID:
15527674
9.

COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery.

Cicconetti A, Bartoli A, Ripari F, Ripari A.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Feb;97(2):139-46.

PMID:
14970772
10.
11.

The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.

Spiegel BM, Targownik L, Dulai GS, Gralnek IM.

Ann Intern Med. 2003 May 20;138(10):795-806. Review.

PMID:
12755551
12.

Supplemental Content

Loading ...
Support Center